Literature DB >> 20536942

Immune response by microglia in the spinal cord.

Julie K Olson1.   

Abstract

Microglia are the resident immune cells of the central nervous system (CNS) and share many immunological characteristics with peripheral macrophage. Microglia exist in a quiescent state in the healthy CNS, however, upon injury or infection, microglia become activated immune cells. Microglia have been implicated in playing an important role in several neurological diseases that affect the spinal cord, especially multiple sclerosis (MS) and neuropathic pain. However, most studies, which examined the immune response by microglia have been conducted using microglia cultures generated from brain microglia. Therefore, our studies examined the immune response by microglia in the spinal cord compared to the immune response by microglia in the brain. Microglia in the spinal cord of mice expressed higher levels of surface immune molecules than microglia in the brain, and upon virus infection, microglia in the spinal cord expressed higher levels of immune molecules than microglia in the brain. These studies suggest that microglia in the spinal cord may have different immune reactivity than microglia in the brain, which may contribute to spinal cord diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20536942     DOI: 10.1111/j.1749-6632.2010.05536.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  17 in total

1.  Unconjugated bilirubin contributes to early inflammation and edema after intracerebral hemorrhage.

Authors:  Matthew C Loftspring; Holly L Johnson; Rui Feng; Aaron J Johnson; Joseph F Clark
Journal:  J Cereb Blood Flow Metab       Date:  2010-11-24       Impact factor: 6.200

2.  Neuroinflammation and virus replication in the spinal cord of simian immunodeficiency virus-infected macaques.

Authors:  Lisa M Mangus; Jamie L Dorsey; Victoria A Laast; Peter Hauer; Suzanne E Queen; Robert J Adams; Justin C McArthur; Joseph L Mankowski
Journal:  J Neuropathol Exp Neurol       Date:  2015-01       Impact factor: 3.685

Review 3.  Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications.

Authors:  Manon Galoppin; Saniya Kari; Sasha Soldati; Arindam Pal; Manon Rival; Britta Engelhardt; Anne Astier; Eric Thouvenot
Journal:  Brain Commun       Date:  2022-06-30

4.  Blockade of gap junction hemichannel protects secondary spinal cord injury from activated microglia-mediated glutamate exitoneurotoxicity.

Authors:  Daisuke Umebayashi; Atsushi Natsume; Hideyuki Takeuchi; Masahito Hara; Yusuke Nishimura; Ryuichi Fukuyama; Naoyuki Sumiyoshi; Toshihiko Wakabayashi
Journal:  J Neurotrauma       Date:  2014-09-23       Impact factor: 5.269

Review 5.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

6.  Culturing microglia from the neonatal and adult central nervous system.

Authors:  Robert Bronstein; Luisa Torres; Jillian C Nissen; Stella E Tsirka
Journal:  J Vis Exp       Date:  2013-08-09       Impact factor: 1.355

7.  Myelin antigen load influences antigen presentation and severity of central nervous system autoimmunity.

Authors:  Ritika Jaini; Daniela C Popescu; Chris A Flask; Wendy B Macklin; Vincent K Tuohy
Journal:  J Neuroimmunol       Date:  2013-04-17       Impact factor: 3.478

8.  Effects of diet on immune cells within the central nervous system.

Authors:  S K Totsch; R Y Meir; R M Orlandella; L A Norian; R E Sorge
Journal:  Physiol Behav       Date:  2018-09-03

Review 9.  Development and treatments of inflammatory cells and cytokines in spinal cord ischemia-reperfusion injury.

Authors:  Ping Zhu; Jia-xin Li; Masayuki Fujino; Jian Zhuang; Xiao-Kang Li
Journal:  Mediators Inflamm       Date:  2013-07-14       Impact factor: 4.711

10.  Reduced inflammatory phenotype in microglia derived from neonatal rat spinal cord versus brain.

Authors:  Sam Joshva Baskar Jesudasan; Kathryn G Todd; Ian R Winship
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.